pharmaceutical investing Cynapsus Therapeutics Up 115% on US$624 million Acquisition by Sunovion Pharmaceuticals
Quebec Innovative Materials Corp. Announces U.S. Affiliate Orvian Receives Minnesota DNR Registration for Exploratory Boring